Latest Breaking News On - அலெக்சியன் மருந்துகள் இன்க் - Page 9 : comparemela.com

Honeywell To Replace Alexion In NASDAQ-100 Index NEW YORK CITY (dpa-AFX) - Nasdaq (NDAQ) said that Honeywell International Inc. (HON) will become a component of the NASDAQ-100 Index, the NASDAQ-100 Equal Weighted Index and the NASDAQ-100 Ex-Technology Index prior to market open on July 21, 2021. Honeywell International Inc. will replace Alexion Pharmaceuticals Inc. (ALXN) in the NASDAQ-100 Index, the NASDAQ-100 Equal Weighted Index and the NASDAQ-100 Ex-Technology Index. Earlier today, the UK Competition and Markets Authority or CMA approved AstraZeneca Plc. s (AZN.L, AZN) proposed acquisition of Alexion Pharmaceuticals. The acquisition is expected to close on 21 July 2021. In December 2020, British drug major AstraZeneca agreed to buy Alexion Pharmaceuticals for $175 per share in cash and stock, valuing the Boston-based company at $39 billion.

United statesUnited kingdomAlexion pharmaceuticalsTechnology indexHoneywell international incAlexion pharmaceuticals incAstrazeneca plcHoneywell internationalWeighted indexUnited kingdom competitionMarkets authorityஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்அலெக்சியன் மருந்துகள்தொழில்நுட்பம் குறியீட்டுஹனிவெல் சர்வதேச இன்க்